amyloid enhancing factor

03/01/2008 - "Studies of amyloid enhancing factor (AEF)-induced amyloidosis are commonly performed in mice. "
10/01/2010 - "Localised cutaneous amyloidosis with different morphology was reproduced in mice by intra-dermal (i.d.) and subdermal administration of amyloid-enhancing factor. "
06/01/1993 - "Splenic macrophage activation and functions in amyloid enhancing factor-induced secondary amyloidosis. "
01/01/1991 - "Amyloid-enhancing factor (AEF) is believed to be a crucial common pathogenetic link in diverse forms of human amyloidosis. "
04/01/1988 - "Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains."

07/01/1999 - "Although amyloid-enhancing factor is not required, its addition to culture medium results in larger and more numerous amyloid deposits. "
03/28/1995 - "Preincubation of amyloid enhancing factor with IDOX significantly reduced the formation of amyloid deposits. "
01/01/2017 - "In the present study, we confirmed the deposition, clearance, and reinduction of AA amyloid deposits in interleukin 1 receptor antagonist knockout mice (IL-1raKO) and studied the SAA levels and amyloid-enhancing factor activity based on the time-dependent changes of amyloid deposition. "
10/01/1997 - "Moreover, amyloid deposition in apoE-deficient mice as well as C57BL/6J control mice started 48 or 72 hours after injection of amyloid-enhancing factor and silver nitrate, although the amount of amyloid deposit in C57BL/6J control mice was slightly larger than that in apoE-deficient mice. "
02/01/1994 - "Previous studies into the nature of the relationship between ubiquitin (UB), possessing intrinsic amyloid enhancing factor (AEF) activity; serum amyloid A (SAA), the precursor protein of AA amyloid; and activated monocytoid cells have indicated a temporal and spatial relationship between these proteins and tissue AA amyloid deposits. "

01/01/2005 - "Amyloid-enhancing factor (AEF) is a biological "activity" that is defined in the context of inflammation-associated amyloidogenesis (AA). "
03/01/1985 - "Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation."
06/01/1999 - "Amyloid enhancing factor (AEF) is an activity that appears naturally during the course of persistent inflammation and precedes, by 24-48 h, AA amyloid deposition in appropriate murine models. "
12/01/1987 - "Administration of amyloid enhancing factor alters experimental inflammation to bring about accelerated deposition of amyloid A fibrils first in spleen and later in other organs. "
09/01/2011 - "Amyloidosis was induced by amyloid-enhancing factor and silver nitrate injection; ASO treatment was initiated 1 week later and continued 1× or 3× per week; inflammation was re-triggered by subsequent injection(s) of silver nitrate; mice were sacrificed after 4-5 weeks. "

10/01/1989 - "Echinococcus multilocularis: characterization of an alveolar hydatid cyst-induced amyloid enhancing factor."
02/01/1988 - "Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis."
02/01/1988 - "The biological activity and time of appearance of alveolar hydatid cyst induced splenic amyloid enhancing factor (AEF) with respect to amyloid deposition in the spleens were determined in C57BL/6J mice. "
02/01/1988 - "Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors."
10/01/1988 - "Low ionic strength acidic buffer, Sephadex G-200 and Benzamidine-Sepharose (BZ) gel chromatography, have been used for the partial purification of alveolar hydatid cyst (AHC) induced amyloid enhancing factor (AEF). "

01/01/1991 - "Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis."
01/01/1988 - "Soluble brain extracts containing 0.1 to 16 mg of protein from 3 normal human brain and 11 patients with Alzheimer's disease, Down's syndrome and other neurological disorders were assayed for amyloid enhancing factor (AEF) activity in the mouse bioassay. "
05/11/1992 - "Tris-HCl or Laemmli sample buffer extracted frontal lobe and hippocampal samples from normal aged and Alzheimer's disease (AD) subjects were used to determine total ubiquitin (Ub), distribution of monomeric Ub and Ub-protein conjugates and amyloid enhancing factor (AEF) activity using the dot-blot, Western blot and mouse AEF bioassay techniques, respectively. "